A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer
Primary Outcome measures are 3-year locoregional control, progression-free and overall
Secondary outcome measures are toxicities scores up to 3 months after surgery (acute) and
greater than 3 months after surgery (late). Data collected at 3-6 month intervals for 30
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
locoregional control, progression-free and overall survival rates.
Peter MacCallum Cancer Centre, Australia
Australia: Department of Health and Ageing Therapeutic Goods Administration